Legend Biotech (LEGN)
32.62
-1.58 (4.62%)
Upcoming Events
Latest Headlines
Legend Biotech Corp. (LEGN) PT Raised to $49 at UBS
June 3, 2026 6:50 AM - StreetInsider
Form 6-K Legend Biotech Corp For: Jun 02
June 2, 2026 9:30 AM - SEC Filing
Legend Biotech to present LB2501 in vivo CAR-T data at EHA conference
June 2, 2026 9:30 AM - StreetInsider
Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL)
June 2, 2026 9:30 AM - StreetInsider
Legend Biotech presents early solid tumor data for LB2102 at ASCO 2026
June 1, 2026 10:00 AM - StreetInsider
Form 6-K Legend Biotech Corp For: Jun 01
June 1, 2026 10:00 AM - SEC Filing
Legend Biotech Presents First-in-Human LB2102 Results in Solid Tumors and New CARVYKTI® Data in Multiple Myeloma at ASCO 2026
June 1, 2026 10:00 AM - StreetInsider
RBC Capital on Legend Biotech Corp. (LEGN): 'We remain buyers'
June 1, 2026 7:48 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
June 1, 2026 6:58 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
May 27, 2026 6:45 AM - StreetInsider
Form 6-K Legend Biotech Corp For: May 21
May 21, 2026 5:00 PM - SEC Filing
Legend Biotech Announces Presentations at ASCO 2026
May 21, 2026 5:00 PM - Globe NewsWire
Legend Biotech Corp. (LEGN) PT Lowered to $48 at Morgan Stanley
May 13, 2026 8:19 AM - StreetInsider
Legend Biotech Corp. (LEGN) PT Raised to $29 at TD Cowen
May 13, 2026 7:50 AM - StreetInsider
Legend Biotech Corp. (LEGN) PT Raised to $64; RBC Capital: 'We see opportunity for share appreciation'
May 13, 2026 7:29 AM - StreetInsider
Legend Biotech (LEGN) Misses Q1 EPS by 16c
May 12, 2026 7:30 AM - StreetInsider
Form 6-K Legend Biotech Corp For: Mar 31
May 12, 2026 7:07 AM - SEC Filing
Legend Biotech Reports First Quarter 2026 Results and Recent Highlights
May 12, 2026 7:00 AM - Globe NewsWire
Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth
May 4, 2026 8:00 AM - StreetInsider
Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results
April 28, 2026 8:01 AM - Globe NewsWire
H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
April 21, 2026 6:36 AM - StreetInsider
Raymond James on Legend Biotech Corp. (LEGN): 'the dataset suggests very strong efficacy with room for improvement on safety'
April 21, 2026 6:31 AM - StreetInsider
RBC on Legend Biotech Corp. (LEGN): 'We Think Shares Remain Undervalued'
April 20, 2026 10:51 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
April 20, 2026 6:35 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
April 15, 2026 7:18 AM - StreetInsider
Form 6-K Legend Biotech Corp For: Apr 14
April 14, 2026 7:30 AM - SEC Filing
Form 4 Legend Biotech Corp For: Mar 25 Filed by: Huang Ying
March 27, 2026 4:27 PM - SEC Filing
Form 144 Legend Biotech Corp Filed by: Huang Ying
March 26, 2026 4:27 PM - SEC Filing
Form 144 Legend Biotech Corp Filed by: Yeung Jessie
March 26, 2026 4:21 PM - SEC Filing
Craig Tendler, M.D., JNJ's Former Global Head of Oncology Clinical Development, to Lead TuHURA Bioscience's VISTA Program in AML and other Blood Related Cancers
March 23, 2026 7:45 AM - PR NewsWire
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Heyman Tomas J.
March 18, 2026 7:05 PM - SEC Filing
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Meng Robin
March 18, 2026 7:03 PM - SEC Filing
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Salovey Peter
March 18, 2026 7:01 PM - SEC Filing
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Casey Patrick John
March 18, 2026 7:00 PM - SEC Filing
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Kung Gareth
March 18, 2026 6:58 PM - SEC Filing
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Mao Li
March 18, 2026 6:57 PM - SEC Filing
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Ji Darren Xiaohui
March 18, 2026 6:56 PM - SEC Filing
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Zhang Fangliang
March 18, 2026 6:54 PM - SEC Filing
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Santos Carlos E
March 18, 2026 6:53 PM - SEC Filing
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Sanders Corazon (Corsee) D.
March 18, 2026 6:51 PM - SEC Filing
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Huang Ying
March 18, 2026 6:50 PM - SEC Filing
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Wang Ye
March 18, 2026 6:49 PM - SEC Filing
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
March 16, 2026 6:11 AM - PR NewsWire
Legend Biotech Corp. (LEGN) PT Lowered to $62 at RBC Capital; 'Shares Should Rebound in 2026'
March 11, 2026 8:46 AM - StreetInsider
Legend Biotech Corp. (LEGN) PT Lowered to $49 at Morgan Stanley
March 10, 2026 5:41 PM - StreetInsider
Raymond James Reiterates Outperform Rating on Legend Biotech Corp. (LEGN) following Q4
March 10, 2026 3:53 PM - StreetInsider
Truist Securities Reiterates Buy Rating on Legend Biotech Corp. (LEGN): "infer from comments that Raritan's full manufacturing slot capacity approved"
March 10, 2026 12:10 PM - StreetInsider
Jefferies Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
March 10, 2026 12:01 PM - StreetInsider
Form 20-F Legend Biotech Corp For: Dec 31
March 10, 2026 11:47 AM - SEC Filing
Legend Biotech (LEGN) Reports In-Line Q4 EPS
March 10, 2026 8:49 AM - StreetInsider
Form 6-K Legend Biotech Corp For: Mar 10
March 10, 2026 7:01 AM - SEC Filing
Legend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights
March 10, 2026 7:00 AM - StreetInsider
Full Article List
